Mon, 13 May 2013
Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 1): Potential Value of Molecular Staging (audio)
Dr. Johannes Kratz, surgeon at Massachusetts General Hospital, explains the potential utility of molecularly guided staging of patients with early stage non-small cell lung cancer (NSCLC).
Direct download: GRACEcast-150_Lung-Audio_Defining_Value_Molecular_Staging_Early_NSCLC.mp3
Category:Lung-Cancer-Audio -- posted at: 12:58pm PDT